65 related articles for article (PubMed ID: 19345712)
1. Influence of TAAR6 polymorphisms on response to aripiprazole.
Serretti A; Pae CU; Chiesa A; Mandelli L; De Ronchi D
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Aug; 33(5):822-6. PubMed ID: 19345712
[TBL] [Abstract][Full Text] [Related]
2. No influence of DTNBP1 polymorphisms on the response to aripiprazole.
Pae CU; Chiesa A; Mandelli L; Serretti A
Neuropsychobiology; 2010; 62(4):245-9. PubMed ID: 20829635
[TBL] [Abstract][Full Text] [Related]
3. TAAR6 variations possibly associated with antidepressant response and suicidal behavior.
Pae CU; Drago A; Kim JJ; Patkar AA; Jun TY; De Ronchi D; Serretti A
Psychiatry Res; 2010 Nov; 180(1):20-4. PubMed ID: 20493543
[TBL] [Abstract][Full Text] [Related]
4. No influence of FAT polymorphisms in response to aripiprazole.
Pae CU; Chiesa A; Mandelli L; De Ronchi D; Serretti A
J Hum Genet; 2010 Jan; 55(1):32-6. PubMed ID: 19893579
[TBL] [Abstract][Full Text] [Related]
5. Association of the trace amine associated receptor 6 (TAAR6) gene with schizophrenia and bipolar disorder in a Korean case control sample.
Pae CU; Yu HS; Amann D; Kim JJ; Lee CU; Lee SJ; Jun TY; Lee C; Paik IH; Patkar AA; Lerer B
J Psychiatr Res; 2008 Jan; 42(1):35-40. PubMed ID: 17097106
[TBL] [Abstract][Full Text] [Related]
6. TAAR6 variation effect on clinic presentation and outcome in a sample of schizophrenic in-patients: an open label study.
Pae CU; Drago A; Kim JJ; Patkar AA; Jun TY; Lee C; Mandelli L; De Ronchi D; Paik IH; Serretti A
Eur Psychiatry; 2008 Sep; 23(6):390-5. PubMed ID: 18583103
[TBL] [Abstract][Full Text] [Related]
7. Long-term efficacy and safety of aripiprazole in patients with schizophrenia, schizophreniform disorder, or schizoaffective disorder: 26-week prospective study.
Kwon JS; Jang JH; Kang DH; Yoo SY; Kim YK; Cho SJ;
Psychiatry Clin Neurosci; 2009 Feb; 63(1):73-81. PubMed ID: 19154213
[TBL] [Abstract][Full Text] [Related]
8. Taq1A polymorphism in the dopamine D2 receptor gene as a predictor of clinical response to aripiprazole.
Kwon JS; Kim E; Kang DH; Choi JS; Yu KS; Jang IJ; Shin SG;
Eur Neuropsychopharmacol; 2008 Dec; 18(12):897-907. PubMed ID: 18786813
[TBL] [Abstract][Full Text] [Related]
9. Influence of DAOA gene variants on antipsychotic response after switch to aripiprazole.
Pae CU; Chiesa A; Serretti A
Psychiatry Res; 2010 Jul; 178(2):430-2. PubMed ID: 20471098
[TBL] [Abstract][Full Text] [Related]
10. The trace amine associated receptor (TAAR6) gene is not associated with schizophrenia in the Irish Case-Control Study of Schizophrenia (ICCSS) sample.
Vladimirov VI; Maher BS; Wormley B; O'Neill FA; Walsh D; Kendler KS; Riley BP
Schizophr Res; 2009 Feb; 107(2-3):249-54. PubMed ID: 18973992
[TBL] [Abstract][Full Text] [Related]
11. Immediate versus gradual suspension of previous treatments during switch to aripiprazole: results of a randomized, open label study.
Pae CU; Serretti A; Chiesa A; Mandelli L; Lee C; Lee C; Kim J; De Ronchi D; Paik IH
Eur Neuropsychopharmacol; 2009 Aug; 19(8):562-70. PubMed ID: 19442491
[TBL] [Abstract][Full Text] [Related]
12. Aripiprazole for the treatment of psychoses in institutionalized patients with Alzheimer dementia: a multicenter, randomized, double-blind, placebo-controlled assessment of three fixed doses.
Mintzer JE; Tune LE; Breder CD; Swanink R; Marcus RN; McQuade RD; Forbes A
Am J Geriatr Psychiatry; 2007 Nov; 15(11):918-31. PubMed ID: 17974864
[TBL] [Abstract][Full Text] [Related]
13. Effects of DRD2/ANKK1 gene variations and clinical factors on aripiprazole efficacy in schizophrenic patients.
Shen YC; Chen SF; Chen CH; Lin CC; Chen SJ; Chen YJ; Luu SU
J Psychiatr Res; 2009 Mar; 43(6):600-6. PubMed ID: 18926547
[TBL] [Abstract][Full Text] [Related]
14. A region of 35 kb containing the trace amine associate receptor 6 (TAAR6) gene is associated with schizophrenia in the Irish study of high-density schizophrenia families.
Vladimirov V; Thiselton DL; Kuo PH; McClay J; Fanous A; Wormley B; Vittum J; Ribble R; Moher B; van den Oord E; O'Neill FA; Walsh D; Kendler KS; Riley BP
Mol Psychiatry; 2007 Sep; 12(9):842-53. PubMed ID: 17505468
[TBL] [Abstract][Full Text] [Related]
15. A 12-week randomized, open-label study of perospirone versus aripiprazole in the treatment of Japanese schizophrenia patients.
Takekita Y; Kato M; Wakeno M; Sakai S; Suwa A; Nishida K; Okugawa G; Kinoshita T
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jan; 40():110-4. PubMed ID: 23022672
[TBL] [Abstract][Full Text] [Related]
16. Effects of the DRD3 Ser9Gly polymorphism on aripiprazole efficacy in schizophrenic patients as modified by clinical factors.
Chen SF; Shen YC; Chen CH
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):470-4. PubMed ID: 19302829
[TBL] [Abstract][Full Text] [Related]
17. Trial of aripiprazole in the treatment of first-episode schizophrenia.
Lee HY; Ham BJ; Kang RH; Paik JW; Hahn SW; Lee MS; Lee MS
Psychiatry Clin Neurosci; 2010 Feb; 64(1):38-43. PubMed ID: 20416024
[TBL] [Abstract][Full Text] [Related]
18. Acute antipyschotic efficacy and side effects in schizophrenia: association with serotonin transporter promoter genotypes.
Dolzan V; Serretti A; Mandelli L; Koprivsek J; Kastelic M; Plesnicar BK
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1562-6. PubMed ID: 18573584
[TBL] [Abstract][Full Text] [Related]
19. Epistasis between a set of variations located in the TAAR6 and HSP-70 genes toward schizophrenia and response to antipsychotic treatment.
Pae CU; Drago A; Patkar AA; Jun TY; Serretti A
Eur Neuropsychopharmacol; 2009 Nov; 19(11):806-11. PubMed ID: 19643584
[TBL] [Abstract][Full Text] [Related]
20. Effects of aripiprazole and the Taq1A polymorphism in the dopamine D2 receptor gene on the clinical response and plasma monoamine metabolites level during the acute phase of schizophrenia.
Miura I; Takeuchi S; Katsumi A; Mori A; Kanno K; Yang Q; Mashiko H; Numata Y; Niwa S
J Clin Psychopharmacol; 2012 Feb; 32(1):106-9. PubMed ID: 22198450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
